The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation

Shamir Haji, Ryan Planchard, Adeel Zubair, Jonathan Graff-Radford, Charlotte Rydberg, Robert D Jr. Brown, Kelly Flemming

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The clinical significance of cerebral microbleeds (CMB) in patients hospitalized with atrial fibrillation (AF) and cerebral ischemia is unclear. We aimed to determine the prevalence of CMB in this population and determine the future risk of intracerebral hemorrhage (ICH) and cerebral infarction (CI). The medical records and brain imaging of patients hospitalized with cerebral ischemia due to AF between 2008 and 2011 were reviewed. Followup was obtained through medical record review, mailed survey, and acquisition of death certificates. Prevalence was calculated from those patients with a hemosiderin-sensitive MRI sequence. Recurrent CI and ICH were calculated using Kaplan–Meier curves censored at 3 years. Among 426 patients hospitalized with cerebral ischemia due to AF, 134 had an MRI with hemosiderin-sensitive sequences. The prevalence of CMB was 27.6 %. At 3 years, 90.6 % of CMB-negative patients were overall stroke free (ICH and CI) compared to 78.6 % CMB-positive patients (p = 0.0591). Only one patient in the CMB-positive group had an ICH distant to the CMB. There was a nonsignificant trend toward higher recurrent CI, recurrent overall stroke rate, and mortality in patients with 5 or more CMB compared to 0–4 CMB. The rate of prospective CI in patients with prior cerebral ischemia due to AF is higher than the rate of ICH in patients with CMB. Further study is warranted to assess larger numbers of patients to determine appropriate antithrombotic use in this high-risk population.

Original languageEnglish (US)
Pages (from-to)238-244
Number of pages7
JournalJournal of Neurology
Volume263
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Brain Ischemia
Atrial Fibrillation
Cerebral Hemorrhage
Cerebral Infarction
Hemosiderin
Medical Records
Stroke
Death Certificates
Diagnostic Imaging
Neuroimaging
Population
Mortality

Keywords

  • Atrial fibrillation
  • Cerebral microbleed
  • Intracerebral hemorrhage
  • Prevalence
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation. / Haji, Shamir; Planchard, Ryan; Zubair, Adeel; Graff-Radford, Jonathan; Rydberg, Charlotte; Brown, Robert D Jr.; Flemming, Kelly.

In: Journal of Neurology, Vol. 263, No. 2, 01.02.2016, p. 238-244.

Research output: Contribution to journalArticle

@article{6547151ae4ee41a09189625db0185c96,
title = "The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation",
abstract = "The clinical significance of cerebral microbleeds (CMB) in patients hospitalized with atrial fibrillation (AF) and cerebral ischemia is unclear. We aimed to determine the prevalence of CMB in this population and determine the future risk of intracerebral hemorrhage (ICH) and cerebral infarction (CI). The medical records and brain imaging of patients hospitalized with cerebral ischemia due to AF between 2008 and 2011 were reviewed. Followup was obtained through medical record review, mailed survey, and acquisition of death certificates. Prevalence was calculated from those patients with a hemosiderin-sensitive MRI sequence. Recurrent CI and ICH were calculated using Kaplan–Meier curves censored at 3 years. Among 426 patients hospitalized with cerebral ischemia due to AF, 134 had an MRI with hemosiderin-sensitive sequences. The prevalence of CMB was 27.6 {\%}. At 3 years, 90.6 {\%} of CMB-negative patients were overall stroke free (ICH and CI) compared to 78.6 {\%} CMB-positive patients (p = 0.0591). Only one patient in the CMB-positive group had an ICH distant to the CMB. There was a nonsignificant trend toward higher recurrent CI, recurrent overall stroke rate, and mortality in patients with 5 or more CMB compared to 0–4 CMB. The rate of prospective CI in patients with prior cerebral ischemia due to AF is higher than the rate of ICH in patients with CMB. Further study is warranted to assess larger numbers of patients to determine appropriate antithrombotic use in this high-risk population.",
keywords = "Atrial fibrillation, Cerebral microbleed, Intracerebral hemorrhage, Prevalence, Stroke",
author = "Shamir Haji and Ryan Planchard and Adeel Zubair and Jonathan Graff-Radford and Charlotte Rydberg and Brown, {Robert D Jr.} and Kelly Flemming",
year = "2016",
month = "2",
day = "1",
doi = "10.1007/s00415-015-7966-2",
language = "English (US)",
volume = "263",
pages = "238--244",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "D. Steinkopff-Verlag",
number = "2",

}

TY - JOUR

T1 - The clinical relevance of cerebral microbleeds in patients with cerebral ischemia and atrial fibrillation

AU - Haji, Shamir

AU - Planchard, Ryan

AU - Zubair, Adeel

AU - Graff-Radford, Jonathan

AU - Rydberg, Charlotte

AU - Brown, Robert D Jr.

AU - Flemming, Kelly

PY - 2016/2/1

Y1 - 2016/2/1

N2 - The clinical significance of cerebral microbleeds (CMB) in patients hospitalized with atrial fibrillation (AF) and cerebral ischemia is unclear. We aimed to determine the prevalence of CMB in this population and determine the future risk of intracerebral hemorrhage (ICH) and cerebral infarction (CI). The medical records and brain imaging of patients hospitalized with cerebral ischemia due to AF between 2008 and 2011 were reviewed. Followup was obtained through medical record review, mailed survey, and acquisition of death certificates. Prevalence was calculated from those patients with a hemosiderin-sensitive MRI sequence. Recurrent CI and ICH were calculated using Kaplan–Meier curves censored at 3 years. Among 426 patients hospitalized with cerebral ischemia due to AF, 134 had an MRI with hemosiderin-sensitive sequences. The prevalence of CMB was 27.6 %. At 3 years, 90.6 % of CMB-negative patients were overall stroke free (ICH and CI) compared to 78.6 % CMB-positive patients (p = 0.0591). Only one patient in the CMB-positive group had an ICH distant to the CMB. There was a nonsignificant trend toward higher recurrent CI, recurrent overall stroke rate, and mortality in patients with 5 or more CMB compared to 0–4 CMB. The rate of prospective CI in patients with prior cerebral ischemia due to AF is higher than the rate of ICH in patients with CMB. Further study is warranted to assess larger numbers of patients to determine appropriate antithrombotic use in this high-risk population.

AB - The clinical significance of cerebral microbleeds (CMB) in patients hospitalized with atrial fibrillation (AF) and cerebral ischemia is unclear. We aimed to determine the prevalence of CMB in this population and determine the future risk of intracerebral hemorrhage (ICH) and cerebral infarction (CI). The medical records and brain imaging of patients hospitalized with cerebral ischemia due to AF between 2008 and 2011 were reviewed. Followup was obtained through medical record review, mailed survey, and acquisition of death certificates. Prevalence was calculated from those patients with a hemosiderin-sensitive MRI sequence. Recurrent CI and ICH were calculated using Kaplan–Meier curves censored at 3 years. Among 426 patients hospitalized with cerebral ischemia due to AF, 134 had an MRI with hemosiderin-sensitive sequences. The prevalence of CMB was 27.6 %. At 3 years, 90.6 % of CMB-negative patients were overall stroke free (ICH and CI) compared to 78.6 % CMB-positive patients (p = 0.0591). Only one patient in the CMB-positive group had an ICH distant to the CMB. There was a nonsignificant trend toward higher recurrent CI, recurrent overall stroke rate, and mortality in patients with 5 or more CMB compared to 0–4 CMB. The rate of prospective CI in patients with prior cerebral ischemia due to AF is higher than the rate of ICH in patients with CMB. Further study is warranted to assess larger numbers of patients to determine appropriate antithrombotic use in this high-risk population.

KW - Atrial fibrillation

KW - Cerebral microbleed

KW - Intracerebral hemorrhage

KW - Prevalence

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84957844974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957844974&partnerID=8YFLogxK

U2 - 10.1007/s00415-015-7966-2

DO - 10.1007/s00415-015-7966-2

M3 - Article

C2 - 26566908

AN - SCOPUS:84957844974

VL - 263

SP - 238

EP - 244

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 2

ER -